A phase II study of irinotecan (CPT-11) alternated with a weekly schedule of oxaliplatin (L-OHP), high-dose leucovorin (LV) and a 48-hour infusion 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer (MCRC)
Year: 2001
Type: article
Source: European Journal of Cancer
Authors: G. Rosati, A. Tucci, A. Rinaldi, D. Colarusso, A. Rossi, C. Pizza, L. Manzione
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2003148266